1. 2022-RA-1312-ESGO Feasibility of carboplatin monotherapy versus carboplatin-paclitaxel in frail elderly epithelial ovarian cancer patients. (20th October 2022) Authors: Yu, Tamara; Kesmez, Ronas Taner; Flynn, MJ; Ledermann, JA; Lockley, M; MacDonald, N; McCormack, M; Nicum, S; Crusz, SM; Miller, RE; Merry, Eve Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. Issue 9 (September 2019) Authors: de Boer, Stephanie M; Powell, Melanie E; Mileshkin, Linda; Katsaros, Dionyssios; Bessette, Paul; Haie-Meder, Christine; Ottevanger, Petronella B; Ledermann, Jonathan A; Khaw, Pearly; D'Amico, Romerai; Fyles, Anthony; Baron, Marie-Helene; Jürgenliemk-Schulz, Ina M; Kitchener, Henry C; Nijman, Hans... Journal: Lancet oncology Issue: Volume 20:Issue 9(2019) Page Start: 1273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bevacizumab combined with first-line carboplatin and paclitaxel for metastatic/recurrent/persistent cervical cancer: primary results from the global single-arm phase II CECILIA study. (1st November 2019) Authors: Colombo, N; Dreosti, L; McCormack, M; Nogueira-Rodrigues, A; Scambia, G; Roszak, A; Donica, M; Ulker, B; González-Martín, A; Redondo, A Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bilateral fibrosarcoma of the epididymis. Issue 7 (July 1975) Authors: McCormack, M Journal: Journal of clinical pathology Issue: Volume 28:Issue 7(1975) Page Start: 576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Caecal rupture in psychotic patients. Issue 5936 (12th October 1974) Authors: McCormack, M Journal: BMJ Issue: Volume 4:Issue 5936(1974) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Diagnostic potential of lysosomal hydrolases in body cavity effusions. Issue 2 (February 1976) Authors: McCormack, M Journal: Journal of clinical pathology Issue: Volume 29:Issue 2(1976) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. G267 Improving the Quality of Hospital Discharge in Babies with Down Syndrome: Part One of a Quality Improvement Study. (24th May 2017) Authors: Moore, CM; Eldaw, S; McCormack, M; Fitzsimons, J Journal: Archives of disease in childhood Issue: Volume 102(2017)Supplement 1 Page Start: A105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. G359(P) An audit of trainee proficiency in the use of the RCPCH early years UK-WHO growth charts. (27th April 2016) Authors: McGlacken-Byrne, SM; McCormack, M Journal: Archives of disease in childhood Issue: Volume 101:Supplement 1(2016) Page Start: A211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Optimization of propagation-based x-ray phase-contrast tomography for breast cancer imaging. (24th February 2017) Authors: Baran, P; Pacile, S; Nesterets, Y I; Mayo, S C; Dullin, C; Dreossi, D; Arfelli, F; Thompson, D; Lockie, D; McCormack, M; Taba, S T; Brun, F; Pinamonti, M; Nickson, C; Hall, C; Dimmock, M; Zanconati, F; Cholewa, M; Quiney, H; Brennan, P C Journal: Physics in medicine & biology Issue: Volume 62:Number 6(2017:Mar.) Page Start: 2315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P401 Association between induction vedolizumab drug levels and therapy outcome in inflammatory bowel disease. (25th January 2019) Authors: O'Connell, J; Ismail, M S; McCormack, M; McDonagh, P; Argue, R; Breslin, N; Crowley, V; Cullen, G; Doherty, G A; Dunne, C; Hartery, K; MacCarthy, F; McKiernan, S; Mulcahy, H; O'Connor, A; O'Morain, C; Ryan, B; Sheridan, J; Healy, M; McNamara, D Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗